financetom
Business
financetom
/
Business
/
What's Going On With NIO Shares On Friday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With NIO Shares On Friday?
May 24, 2024 8:04 AM

NIO Inc. ( NIO ) shares are trading slightly lower on Friday. 

The Chinese EV manufacturer published a notice to announce that it will hold an annual general meeting of shareholders on June 25, 2024. The company will publish its first-quarter results on June 6. 

The company is currently in the headlines for adding a new NIO House in the Netherlands as it moves ahead with efforts to expand in Europe.

The NIO House, NIO’s largest in Europe so far, spans eight floors and covers a total area of 2,768 square meters, CnEV Post reported. In contrast, NIO Houses in China typically consist of only two floors.

Following the Rotterdam opening on March 23, 2023, the NIO House in the Netherlands becomes NIO’s second establishment in the country.

In the past year, NIO expanded with smaller centers in Europe, like those in the Netherlands and Denmark, according to CnEV Post. Now, it’s shifting its service system, including battery swap stations, to Europe.

In 2022, NIO established its first overseas plant, the NIO Power Europe Plant in Hungary, manufacturing battery swap stations. Currently, NIO operates 43 swap stations in Europe, notably 15 in Germany, compared to 2,420 in China, the report noted.

Price Action: NIO shares are trading lower by 0.31% to $4.785 at last check Friday. 

Read Next: Comcast Plans $138M Fiber Network Expansion In Utah

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Toymaker Hasbro's turnaround efforts help Q1 profit beat, ease sales decline
Toymaker Hasbro's turnaround efforts help Q1 profit beat, ease sales decline
Apr 24, 2024
(Reuters) -Hasbro ( HAS ) reported a smaller-than-expected drop in first-quarter sales and easily beat profit estimates on Wednesday, as leaner inventories and steady digital gaming revenue helped cushion a drag from softer demand for toys. Shares of the company, up roughly 14% this year, rose about 4% in premarket trading. The Play-Doh maker has grappled with weakening demand over...
Humana beats first-quarter profit estimates on strength of Medicare business
Humana beats first-quarter profit estimates on strength of Medicare business
Apr 24, 2024
April 24 (Reuters) - Humana beat first-quarter profit expectations on Wednesday, helped by strength in its government-backed Medicare Advantage insurance business for older adults. On an adjusted basis, Humana reported a profit of $7.23 per share, higher than the average analyst estimate of $6.12 per share, according to LSEG data. (Reporting by Mariam Sunny and Leroy Leo in Bengaluru; Editing...
Thermo Fisher's Fiscal Q1 Adjusted Earnings Rise While Revenue Falls; Fiscal 2024 Outlook Updated -- Shares Advance Pre-Bell
Thermo Fisher's Fiscal Q1 Adjusted Earnings Rise While Revenue Falls; Fiscal 2024 Outlook Updated -- Shares Advance Pre-Bell
Apr 24, 2024
06:46 AM EDT, 04/24/2024 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) reported fiscal Q1 adjusted earnings Wednesday of $5.11 per diluted share, up from $5.03 a year earlier. Analysts polled by Capital IQ expected $4.71. Revenue for the quarter ended March 30 was $10.34 billion, down from $10.71 billion a year earlier. Analysts surveyed by Capital IQ expected...
Biogen beats quarterly profit estimates, Alzheimer's drug sales jump
Biogen beats quarterly profit estimates, Alzheimer's drug sales jump
Apr 24, 2024
April 24 (Reuters) - Biogen beat Wall Street estimates for first-quarter profit on Wednesday, helped by a series of cost-cutting measures as older drugs face fierce competition. The company also said its Alzheimer's drug Leqembi, developed with Japanese partner Eisai ( ESALF ), recorded global sales of about $19 million, nearly tripling from the fourth quarter of 2023. The number...
Copyright 2023-2025 - www.financetom.com All Rights Reserved